20 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
THE MEETING
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS
PROPOSAL 1
CORPORATE GOVERNANCE
Composition of the Board of Directors
Board … information regarding the experiences, qualifications, attributes, or skills that caused the Nominating and Corporate Governance Committee
424B4
COYA
Coya Therapeutics Inc
12 May 23
Prospectus supplement with pricing info
4:16pm
of Nasdaq, such as the corporate governance requirements or the $1.00 Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2
POS AM
i1u4xlp8g
8 May 23
Prospectus update (post-effective amendment)
9:00am
10-K
bhd2c
29 Mar 23
Annual report
4:08pm
10-K
EX-3.2
rh4dbki
29 Mar 23
Annual report
4:08pm
424B4
3ef6j2b4h6gs311whl4o
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
i0t5em8yc xx0
5 Dec 22
IPO registration (amended)
8:16am
S-1
4sz9zr5ery5xif96
18 Nov 22
IPO registration
5:06pm
S-1
EX-3.4
yzc plttoc
18 Nov 22
IPO registration
5:06pm
DRS/A
EX-3
w9gr83 3h
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
dr7tg6saoa1 40nvan
28 Oct 22
Draft registration statement (amended)
12:00am
DRSLTR
kre9g xjzxbf
7 Oct 22
Correspondence regarding draft registration statement
12:00am
DRS/A
f8tn6ab1f
7 Oct 22
Draft registration statement (amended)
12:00am
UPLOAD
cl4ausukn
15 Sep 22
Letter from SEC
12:00am
DRS
n8s2j4v2q 6hio3t9
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next